Comparative study of cytokine storm treatment in patients with COVID-19 pneumonia using immunomodulators

F Marc, CM Moldovan, A Hoza, S Magheru… - Journal of Clinical …, 2022 - mdpi.com
(1) Background: In patients hospitalized with COVID-19 pneumonia, especially moderate
and severe forms, a cytokine storm may occur, characterized by the worsening of symptoms …

Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study

AM Al-Qaaneh, FH Al-Ghamdi, S AbdulAzeez… - Pharmaceutics, 2022 - mdpi.com
Severe acute respiratory coronavirus-2 (SARS-CoV-2) still presents a public threat and puts
extra strain on healthcare facilities. Without an effective antiviral drug, all available treatment …